NCT00142779View on ClinicalTrials.gov

Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

January 31, 2006

Study Completion Date

March 31, 2006

Conditions
Cocaine-Related DisordersOpioid-Related Disorders
Interventions
DRUG

Fluoxetine

Trial Locations (1)

21224

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00142779 - Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts | Biotech Hunter | Biotech Hunter